Clarivate partners with KYBORA to expand biopharma transaction advisory services
CLVT•Clarivate and KYBORA expand biopharma transaction advisory services
Clarivate partnered with investment bank KYBORA to provide end-to-end transaction advisory services for biopharma companies.
The offering targets strategic transactions including M&A, licensing, and capital raising, combining life sciences intelligence with deal execution support.
The partnership aims to help clients assess asset value, sharpen investment narratives, engage partners earlier, and improve transaction outcomes.
KYBORA has completed nearly 100 biopharma M&A, licensing, and fundraising transactions worldwide.
Coverage spans North America, Europe, Latin America, and Asia Pacific to reach key biopharma markets and investor communities.
